Early Results From the First Cas12-Mediated Clinical Trial
Time: 9:00 am
day: Day 1 AM
Details:
- Outlining the rationale behind selecting AsCas12a and potential differentiation
- Presenting interim safety and efficacy data from ongoing AsCas12a based clinical trials
- Key considerations for the future of genome editing clinical development
